C. Gazengel

发表

French Previously Untreated Patients with Severe Hemophilia A after Exposure to Recombinant Factor VIII : Incidence of Inhibitor and Evaluation of Immune Tolerance

P. Moreau, C. Rothschild, J. Goudemand, 1998, Thrombosis and Haemostasis.

Frequent lymphocytes infection by hepatitis B virus in haemophiliacs

C. Bréchot, L. Chatenoud, C. Gazengel, 1987, British journal of haematology.

Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.

H. Bismuth, C. Bréchot, L. Chatenoud, 1986, Journal of hepatology.

A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.

M. Vidaud, J. Cazenave, C. Gazengel, 1986, Blood.

Evaluation of desmopressin for dental extractions in patients with hemostatic disorders.

M. Torchet, J. Goudemand, C. Gazengel, 1994, Oral surgery, oral medicine, and oral pathology.

Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group.

H. Brackmann, I. Scharrer, T. Abshire, 2000, Thrombosis and haemostasis.

Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling

M. Vidaud, D. Vidaud, M. Goossens, 1993, Human Genetics.

Monoclonal anti‐HBs antibodies radioimmunoassay and serum HBV‐DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAgnegative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors

F. Carnot, C. Bréchot, S. Pol, 1987, European journal of clinical investigation.

Hepatitis C virus genotypes in French haemophiliacs: Kinetics and reappraisal of mixed infections

C. Bréchot, S. Pol, C. Rothschild, 1997, Journal of medical virology.

TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE

P. Mannucci, K. Schimpf, C. Gazengel, 1985, The Lancet.

Efficacy of a sucrose‐formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A

M. Ragni, H. Brackmann, I. Scharrer, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Sucrose Formulated Recombinant Human Antihemophilic Factor VIII Is Safe and Efficacious for Treatment of Hemophilia A in Home Therapy

H. Brackmann, I. Scharrer, T. Abshire, 2000, Thrombosis and Haemostasis.

Hereditary nephritis associated with May-Hegglin anomaly.

C. Gazengel, R. Girot, F. Brivet, 1981, Nephron.

Autologous Blood Donation for Elective Surgery in Children Weighing 8–25 kg

G. Barrier, C. Gazengel, J. Merckx, 1996, Vox sanguinis.

HIV infection in haemophilia--a European cohort.

E. MAUSER‐BUNSCHOTEN, E. Scheibel, F. Hill, 1993, Archives of disease in childhood.

Use of HBV vaccine in hemophiliacs.

C. Bréchot, M. Torchet, F. Degos, 2009, Scandinavian journal of haematology. Supplementum.

ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS

A. Fischer, C. Griscelli, J. Chermann, 1984, The Lancet.

Intracranial hemorrhages in children with hemophilia: medical and surgical treatment.

J. Hirsch, A. Zouaoui, D. Rénier, 1983, Acta neurologica.

Antibody‐induced von willebrand syndrome: Inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoanti body

A. Prieur, C. Gazengel, J. Nedellec, 1978, American journal of hematology.

Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.

F. Brun-Vézinet, C. Rouzioux, D. Klatzmann, 1985, Annals of internal medicine.

Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.

M. Leuther, Y. Laurian, C. Gazengel, 1987, The New England journal of medicine.

HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1).

L. Meyer, Y. Sultan, J. Peynet, 1996, Hematology and cell therapy.

Progression to AIDS in French haemophiliacs: association with HLA-B35.

D. Costagliola, Y. Laurian, Y. Sultan, 1993, AIDS.

Possible genetic susceptibility to the acquired immunodeficiency syndrome in hemophiliacs.

Y. Sultan, C. Gazengel, P. Maisonneuve, 1986, Annals of internal medicine.

Monoclonal Immunoglobulins in Haemophiliac Patients with HIV Infection

M. Torchet, C. Gazengel, A. Fischer, 1991, Thrombosis and Haemostasis.

Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.

M. Torchet, C. Rothschild, M. Dautzenberg, 1988, Nouvelle revue francaise d'hematologie.

Deletion in prion protein gene in a Moroccan family.

J. Laplanche, M. Vidaud, J. Launay, 1990, Nucleic acids research.

LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

P. Jungers, J. Bach, M. Dautzenberg, 1984, The Lancet.

[Unusual leukemic syndrome in a newborn with 21 trisomy: megakaryocyte and platelet proliferation; disseminated intravascular coagulation syndrome].

C. Gazengel, P. Desprès, A. Cosson, 1974, Nouvelle revue francaise d'hematologie.

Tentative localization of a Hageman (factor XII) locus on 7q, probably the 7q35 band

C. Gazengel, C. Turleau, F. Josso, 2004, Humangenetik.

Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group.

A. Goudeau, C. Guérois, Y. Laurian, 1985, Blood.

Non‐A, Non‐B Hepatitis in Hemophilic Patients with Inhibitor Treated with Activated Prothrombin Complex Concentrates: Lack of Correlation with an Antigen Possibly Related to Non‐A, Non‐B Hepatitis

Y. Laurian, C. Gazengel, J. Hellings, 1984, Vox sanguinis.

The Role of HIV Infectivity and Composition of Factor VIII Concentrates on the Immunity of Haemophiliacs Positive for HIV Antibodies

Y. Sultan, C. Gazengel, C. Bosser, 1987, Vox sanguinis.

Vaccination against Hepatitis A Virus in French Hemophilic Children

S. Pol, C. Rothschild, C. Gazengel, 1995, Vox sanguinis.